SELLAS Life Sciences Group, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
SLS Company Description
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
SLS Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view SLS Smart Score
Score Breakdown
SLS Company Description
Show More
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of SLS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SLS's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on SLS's company Twitter account
WallStreetBets
Number of mentions of SLS in WallStreetBets Daily Discussion
SLS News
Recent insights relating to SLS
CNBC Recommendations
Recent picks made for SLS stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in SLS
Corporate Flights
Flights by private jets registered to SLS
Our Analysis